These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 18948162

  • 1. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C, Brecher M, Hamer-Maansson JE, Winter H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):199-204. PubMed ID: 18948162
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.
    Meulien D, Huizar K, Brecher M.
    Hum Psychopharmacol; 2010 Mar 17; 25(2):103-15. PubMed ID: 20196185
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.
    Clin Ther; 2011 Nov 17; 33(11):1643-58. PubMed ID: 22054797
    [Abstract] [Full Text] [Related]

  • 11. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
    Cutler AJ, Tran-Johnson T, Kalali A, Aström M, Brecher M, Meulien D.
    Psychopharmacol Bull; 2010 Nov 17; 43(4):37-69. PubMed ID: 21240151
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications.
    Bui K, Earley W, Nyberg S.
    Curr Med Res Opin; 2013 Jul 17; 29(7):813-25. PubMed ID: 23574265
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
    De Deyn PP, Eriksson H, Svensson H, Study 115 investigators.
    Int J Geriatr Psychiatry; 2012 Mar 17; 27(3):296-304. PubMed ID: 21538537
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia.
    Li Q, Su YA, Liu Y, Chen JX, Tan YL, Yang FD, Si TM.
    Clin Pharmacokinet; 2014 May 17; 53(5):455-65. PubMed ID: 24385309
    [Abstract] [Full Text] [Related]

  • 16. Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study.
    Peuskens J, Trivedi JK, Brecher M, Miller F, Study 4 Investigators.
    Int Clin Psychopharmacol; 2010 May 17; 25(3):183-7. PubMed ID: 20216222
    [Abstract] [Full Text] [Related]

  • 17. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
    Locklear JC, Alemayehu B, Brody RS, Chavoshi S, Tunceli O, Kern D, Earley WR.
    Clin Ther; 2013 Dec 17; 35(12):1923-32. PubMed ID: 24275622
    [Abstract] [Full Text] [Related]

  • 18. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M, Chang S, Hellriegel ET.
    Clin Ther; 2009 Jan 17; 31(1):108-14. PubMed ID: 19243711
    [Abstract] [Full Text] [Related]

  • 19. Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.
    Winter HR, Earley WR, Hamer-Maansson JE, Davis PC, Smith MA.
    J Child Adolesc Psychopharmacol; 2008 Feb 17; 18(1):81-98. PubMed ID: 18294091
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.